Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen

Last updated: December 13, 2013
Sponsor: UCB Pharma
Overall Status: Completed

Phase

3

Condition

Nasal Obstruction

Common Cold

Allergy

Treatment

N/A

Clinical Study ID

NCT00315523
A00415
  • Ages > 18
  • All Genders

Study Summary

To compare the clinical efficacy of levocetirizine 5 mg and montelukast 10 mg, administered once daily during two consecutive days, on symptoms of seasonal allergic rhinitis occurring in subjects exposed to ragweed pollen in an environmental exposure unit.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Have had seasonal allergic rhinitis due to Ragweed for the last 2 consecutive years

  • Subjects who obtain a minimum sum score, considering SAR related symptoms (meanvalue), as defined by the protocol

Exclusion

Exclusion Criteria:

  • Any clinically significant condition that might interfere with the treatmentevaluation, both for efficacy and safety

  • Have used forbidden concomitant medications as defined by the protocol

Study Design

Total Participants: 403
Study Start date:
July 01, 2006
Estimated Completion Date:
October 31, 2006

Connect with a study center

  • Mississauga, Ontario
    Canada

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.